Neuralink, the medical engineering company owned by Elon Musk, has called for volunteers to assist in testing technology aimed at helping individuals with "quadriplegic" cerebral palsy. The company intends to implant a computer chip in the brains of individuals suffering from quadriplegic cerebral palsy to enter the human trial phase of this project, which aims to assist those with severe physical disabilities. In this plan, a computer chip, once implanted in the brains of volunteers, will serve as an interface between the brain and a computer, enabling individuals with severe physical disabilities to use a computer for their needs and type on its screen merely by thinking. Neuralink successfully obtained approval from the U.S. Food and Drug Administration for its first human trial earlier this year. This authorization allows the company to implant its computer chip in the brains of 10 individuals suffering from cerebral palsy, multiple sclerosis, and spinal cord injuries. Elon Musk's company has announced that the first phase of human trials will take approximately six years, during which surgical robots will place the chip in the part of the brain responsible for decision-making and our will to move. The first brain-computer interface chip was implanted in a human by Black Rock in 2004. Another company, Precision Neuroscience, is also concurrently researching and testing similar projects to assist individuals with severe mobility limitations. A conversation with Dr. Shahram Majidi, who implanted the first brain-computer interface chip in the U.S., highlights the significance of this technology. Elon Musk has been named "Person of the Year" by Time magazine, marking another achievement for him, alongside a monkey that plays games using its mind. What do we know about Elon Musk's brain implant technology? It is a smart chip designed to assist individuals with mobility impairments.
Elon Musk's Company Seeks Volunteers; Neuralink Pursues Treatment for Cerebral Palsy
Neuralink, owned by Elon Musk, is seeking volunteers for human trials of a brain-computer interface aimed at helping individuals with severe mobility impairments, particularly those with cerebral palsy. The FDA has approved the first human trials, which will last about six years. This technology could significantly enhance the quality of life for those with severe disabilities.
👥 Key Players
📰 What Happened
Neuralink is seeking volunteers for human trials of a brain-computer interface designed to assist individuals with severe mobility impairments, particularly those with quadriplegic cerebral palsy. The FDA has approved these trials, which will last about six years.
- Neuralink aims to implant a chip that allows users to control computers with their thoughts.
- The first phase of trials will involve 10 individuals with various mobility impairments.
💡 Why It Matters
📚 Background
Brain-computer interfaces are emerging technologies that connect the brain directly to computers, offering new possibilities for individuals with severe mobility limitations. Neuralink's work is part of a broader trend in neurotechnology.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%